NYSEARCA:BBH

Vaneck Vectors Biotech Etf ETF News

Financial Services > Asset Management

Buy BBH

*Your capital is at risk

$205.55

-2.46 (-1.18%)

At Close: Jul 31, 2026

Biotech IPOs on pace for near-record year - WSJ

12:00am, Wednesday, 31'st Oct 2018

Why ultra-low fees can be a serious red flag for unwary ETF investors

12:59pm, Monday, 29'th Oct 2018

Investors must be wary of hidden fees that lurk with ETFs, even though fund fees are on a steady decline. Experts suggest investors follow a handful of rules to help navigate the marketplace.

Analysts (literally) in the green from biotech boom

12:00am, Wednesday, 29'th Aug 2018

Biotech ETFs in Focus on String of Q2 Earnings Beat

12:00am, Friday, 10'th Aug 2018

Biotech ETFs Surge on Biogen's Positive Drug Trial Result

12:00am, Monday, 09'th Jul 2018

Top-Ranked Sector ETFs to Buy for Q3

12:00am, Wednesday, 27'th Jun 2018

Investors bullish on biotechs after Trump drug pricing speech

12:00am, Friday, 18'th May 2018

Trump speech on drug prices light on specifics

12:00am, Friday, 11'th May 2018

Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down

12:00am, Friday, 04'th May 2018

Healthcare sector in the red premarket on Trump/Xi tariff tit-for-tat

12:00am, Wednesday, 04'th Apr 2018

FDA OKs new blood test for concussions

12:00am, Wednesday, 14'th Feb 2018

3 ETFs to Watch on Biotech Earnings

12:00am, Saturday, 10'th Feb 2018

Under Trump And Gottlieb, Small- And Mid-Cap Biotechs Are A Better Bet Than Large Caps

12:00am, Thursday, 01'st Feb 2018

ETF Watchlist: Week Of January 29, 2018 (IYW, BOTZ, HYGH, IBB)

12:00am, Monday, 29'th Jan 2018

4 ETFs Set to Surge in Q4 Earnings

12:00am, Monday, 15'th Jan 2018

Vaneck Vectors Biotech Etf ETF News

Biotech IPOs on pace for near-record year - WSJ

Why ultra-low fees can be a serious red flag for unwary ETF investors

Analysts (literally) in the green from biotech boom

Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs Surge on Biogen's Positive Drug Trial Result

Top-Ranked Sector ETFs to Buy for Q3

Investors bullish on biotechs after Trump drug pricing speech

Trump speech on drug prices light on specifics

Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down

Healthcare sector in the red premarket on Trump/Xi tariff tit-for-tat

FDA OKs new blood test for concussions

3 ETFs to Watch on Biotech Earnings

Under Trump And Gottlieb, Small- And Mid-Cap Biotechs Are A Better Bet Than Large Caps

ETF Watchlist: Week Of January 29, 2018 (IYW, BOTZ, HYGH, IBB)

4 ETFs Set to Surge in Q4 Earnings

Top Fintech Company